IL-13 Signaling in CD30+ Cutaneous Lymphoproliferative Disorders
Yujie Wen(Peking University), Marshall E. Kadin(Roger Williams Medical Center)
Cited by 5
Related Papers
Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|American Journal Of Pathology|2019|54
CD30 Regulation of IL-13–STAT6 Pathway in Breast Implant–Associated Anaplastic Large Cell Lymphoma
|Aesthetic Surgery Journal|2022|7
SARS-CoV-2 ORF7a Protein Impedes Type I Interferon-Activated JAK/STAT Signaling by Interacting with HNRNPA2B1
|International Journal of Molecular Sciences|2025|2